CLINOLEIC

This brand name is authorized in Austria, Canada, Ecuador, Spain, Finland, France, New Zealand, Poland, Singapore, Turkey, United Kingdom

Active ingredients

The drug CLINOLEIC contains a combination of these active pharmaceutical ingredients (APIs):

1 Olive oil, refined UNII 6UYK2W1W1E - OLIVE OIL

Read about Olive oil, refined

2 Soybean oil, refined UNII 241ATL177A - SOYBEAN OIL

Read about Soybean oil, refined

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
B05BA02	Fat emulsions	B Blood and blood forming organs → B05 Blood substitutes and perfusion solutions → B05B I.V. solutions → B05BA Solutions for parenteral nutrition
Discover more medicines within B05BA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 02344327
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 28541-08-08
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 61977
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 066121, 497368
Country: FR	Base de données publique des médicaments	Identifier(s): 67984396
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 151303, 151393, 348697
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 10049
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100110062
Country: SG	Health Sciences Authority	Identifier(s): 12439P
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8681413880995, 8681413881008, 8681413881015, 8681413881022